Abbott Laboratories (ABT): Price and Financial Metrics


Abbott Laboratories (ABT): $109.45

3.24 (+3.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ABT POWR Grades


  • Stability is the dimension where ABT ranks best; there it ranks ahead of 89.27% of US stocks.
  • ABT's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • ABT ranks lowest in Momentum; there it ranks in the 19th percentile.

ABT Stock Summary

  • ABT has a market capitalization of $211,952,933,671 -- more than approximately 98.98% of US stocks.
  • ABT's went public 36.27 years ago, making it older than 92.84% of listed US stocks we're tracking.
  • In terms of volatility of its share price, ABT is more volatile than only 10.73% of stocks we're observing.
  • Stocks that are quantitatively similar to ABT, based on their financial statements, market capitalization, and price volatility, are DHR, TMO, MDT, NKE, and CMCSA.
  • Visit ABT's SEC page to see the company's official filings. To visit the company's web site, go to www.abbott.com.

ABT Valuation Summary

  • ABT's price/earnings ratio is 35.1; this is 3.84% lower than that of the median Healthcare stock.
  • Over the past 243 months, ABT's price/sales ratio has gone up 0.3.
  • Over the past 243 months, ABT's price/earnings ratio has gone down 10.1.

Below are key valuation metrics over time for ABT.

Stock Date P/S P/B P/E EV/EBIT
ABT 2021-08-31 5.6 6.6 35.1 30.2
ABT 2021-08-30 5.5 6.6 35.0 30.1
ABT 2021-08-27 5.5 6.5 34.6 29.8
ABT 2021-08-26 5.5 6.5 34.9 30.0
ABT 2021-08-25 5.5 6.5 34.7 29.8
ABT 2021-08-24 5.5 6.5 34.9 30.0

ABT Growth Metrics

    The 3 year net income to common stockholders growth rate now stands at 7.15%.
  • Its 5 year revenue growth rate is now at 57.38%.
  • The 5 year net income to common stockholders growth rate now stands at 46.26%.
Over the past 34 months, ABT's revenue has gone up $12,352,000,000.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 43,075 10,533 7,071
2021-09-30 42,308 11,264 7,244
2021-06-30 40,233 10,629 6,376
2021-03-31 37,338 9,823 5,724
2020-12-31 34,608 7,901 4,495
2020-09-30 32,221 6,519 3,382

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
  • ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
  • DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.559 0.557 0.230
2021-03-31 0.527 0.568 0.205
2020-12-31 0.499 0.566 0.166
2020-09-30 0.473 0.567 0.135
2020-06-30 0.462 0.576 0.128
2020-03-31 0.473 0.584 0.147

ABT Price Target

For more insight on analysts targets of ABT, see our ABT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $132.05 Average Broker Recommendation 1.48 (Moderate Buy)

ABT Stock Price Chart Interactive Chart >

Price chart for ABT

ABT Price/Volume Stats

Current price $109.45 52-week high $142.60
Prev. close $106.21 52-week low $101.24
Day low $106.43 Volume 14,301,600
Day high $109.64 Avg. volume 5,933,901
50-day MA $112.91 Dividend yield 1.72%
200-day MA $122.39 Market Cap 191.64B

Abbott Laboratories (ABT) Company Bio


Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013. (Source:Wikipedia)


ABT Latest News Stream


Event/Time News Detail
Loading, please wait...

ABT Latest Social Stream


Loading social stream, please wait...

View Full ABT Social Stream

Latest ABT News From Around the Web

Below are the latest news stories about Abbott Laboratories that investors may wish to consider to help them evaluate ABT as an investment opportunity.

Best Time In Years To Buy These Core Dividend Growth Stocks

Full-Scale Invasion & Full-Scale Market Downturn I don't know about you, but I have been glued to my newsfeed to keep track of the unfolding war in Ukraine. It is the first conventional ground war between two developed nation-states in decades - perhaps since World War II. My earnest hope...

Austin Rogers on Seeking Alpha | February 25, 2022

Abbott (ABT) Down 1.4% Since Last Earnings Report: Can It Rebound?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | February 25, 2022

Got $5,000? These 2 Dividend Kings Are On Sale

A good place to start is by looking at stocks with long track records for not just paying but also increasing their dividend payments. Dividend Kings have raised their payouts for 50 years or more in a row. Abbott Laboratories stock has fallen more than 17% year to date (that's deeper than the S&P 500's decline of less than 9%).

Yahoo | February 24, 2022

Abbott (ABT) Stock Moves -0.22%: What You Should Know

Abbott (ABT) closed the most recent trading day at $117.25, moving -0.22% from the previous trading session.

Yahoo | February 23, 2022

Abbott (ABT) COVID Testing Sales Surge, FX Headwind Stays

Abbott (ABT) registers strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.

Yahoo | February 23, 2022

Read More 'ABT' Stories Here

ABT Price Returns

1-mo -4.72%
3-mo -7.62%
6-mo -22.05%
1-year -1.42%
3-year 38.17%
5-year 143.26%
YTD -21.65%
2021 30.53%
2020 28.04%
2019 22.08%
2018 29.06%
2017 52.03%

ABT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ABT Dividend History

Continue Researching ABT

Here are a few links from around the web to help you further your research on Abbott Laboratories's stock as an investment opportunity:

Abbott Laboratories (ABT) Stock Price | Nasdaq
Abbott Laboratories (ABT) Stock Quote, History and News - Yahoo Finance
Abbott Laboratories (ABT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6268 seconds.